Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30831892 | 0.70 | POLB (0.43) | ALDH1A1KDM4EKMT2AMAPTSMN1; SMN2 | |
| SCHEMBL31527830 | 0.70 | ALDH1A1 (0.46) | ALDH1A1KMT2A | |
| SCHEMBL6410185 | 0.70 | FABP4 (0.44) | ALDH1A1KDM4EHSD17B10KMT2AMAPT | |
| SCHEMBL2807198 | 0.67 | CYP3A4 (0.48) | CYP3A4ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL14387230 | 0.62 | LMNA (0.41) | CYP3A4ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL6952106 | 0.62 | MAPK1 (0.44) | CYP3A4CYP2C19POLBADORA2AADORA2B | |
| SCHEMBL1984602 | 0.61 | MAPK1 (0.40) | CYP3A4ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL30523 | 0.60 | TRIM24 (0.45) | ALDH1A1KMT2AMAPTCYP1A2POLB | |
| SCHEMBL7675118 | 0.60 | NPC1 (0.39) | ALDH1A1KDM4EKMT2AMAPTSMN1; SMN2 | |
| SCHEMBL2720779 | 0.59 | RAB9A (0.33) | CYP3A4ALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0623216-B1 | IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS | UNIV ROCKEFELLER (US) | 2000-09-20 | — | — | EP | claimed |
| US-5733546-A | USING AN ANTIBODY TO REACT WITH AN EPITOPE OF THE AGE'S WHICH IS CROSSREACTIVE WITH AGE'S IN VITRO AND NOT WITH OTHER AGE'S SUCH AS PYRRALINE AND PENTOSIDINE | THE ROCKEFELLER UNIVERSITY (US) | 1998-03-31 | — | — | US | claimed |
| US-5702704-A | Antibodies to in vivo advanced glycosylation endproducts | THE ROCKEFELLER UNIVERSITY (US) | 1997-12-30 | — | — | US | claimed |
| US-5683887-A | Immunochemical detection of in vivo advanced glycosylation endproducts | THE ROCKEFELLER UNIVERSITY (US) | 1997-11-04 | — | — | US | claimed |
| US-5629408-A | Immunochemical isolation of in vivo advanced glycosylation endproducts | THE ROCKEFELLER UNIVERSITY (US) | 1997-05-13 | — | — | US | claimed |
| US-5624804-A | GLYCOSYLATION OF PROTEIN SUCH AS ALBUMIN FOR MEDICAL DIAGNOSIS | THE ROCKEFELLER UNIVERSITY (US) | 1997-04-29 | — | — | US | claimed |
| EP-4388016-A1 | METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASES | Siwa Corporation (US) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024102157-A1 | METHODS AND COMPOSITIONS FOR TREATING DIABETES AND DIABETIC COMPLICATIONS | SIWA CORPORATION (US) | 2024-05-16 | — | — | WO | disclosed |
| US-11958900-B2 | Anti-age antibodies for treating neurodegenerative disorders | SIWA CORPORATION (US) | 2024-04-16 | — | — | US | disclosed |
| US-11873345-B2 | Product and method for treating sarcopenia | SIWA CORPORATION (US) | 2024-01-16 | — | — | US | disclosed |
| US-11872269-B2 | Method and composition for treating sarcopenia | SIWA CORPORATION (US) | 2024-01-16 | — | — | US | disclosed |
| US-20240000930-A1 | METHODS AND COMPOSITIONS FOR TREATING KIDNEY DISEASES | SIWA CORP (US) | 2024-01-04 | — | — | US | disclosed |
| US-11833202-B2 | Method and composition for treating cancer, killing metastatic cancer cells and preventing cancer metastasis using antibody to advanced glycation end products (AGE) | SIWA CORPORATION (US) | 2023-12-05 | — | — | US | disclosed |
| US-5683887-A | Immunochemical detection of in vivo advanced glycosylation endproducts | THE ROCKEFELLER UNIVERSITY (US) | 1997-11-04 | — | — | US | disclosed |
| US-5629408-A | Immunochemical isolation of in vivo advanced glycosylation endproducts | THE ROCKEFELLER UNIVERSITY (US) | 1997-05-13 | — | — | US | disclosed |
| US-5624804-A | GLYCOSYLATION OF PROTEIN SUCH AS ALBUMIN FOR MEDICAL DIAGNOSIS | THE ROCKEFELLER UNIVERSITY (US) | 1997-04-29 | — | — | US | disclosed |
| EP-0688209-A1 | GLYCOSYLATION OF LIPIDS AND LIPID-CONTAINING PARTICLES, AND DIAGNOSTIC AND THERAPEUTIC METHODS AND MATERIALS DERIVED THEREFROM | THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) | 1995-12-27 | — | — | EP | disclosed |
| EP-0623216-A1 | IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS | THE ROCKEFELLER UNIVERSITY (US) | 1994-11-09 | — | — | EP | disclosed |
| WO-1994020083-A1 | GLYCOSYLATION OF LIPIDS AND LIPID-CONTAINING PARTICLES, AND DIAGNOSTIC AND THERAPEUTIC METHODS AND MATERIALS DERIVED THEREFROM | THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) | 1994-09-15 | — | — | WO | disclosed |
| WO-1993013421-A1 | IMMUNOCHEMICAL DETECTION OF IN VIVO ADVANCED GLYCOSYLATION ENDPRODUCTS | THE ROCKEFELLER UNIVERSITY (US) | 1993-07-08 | — | — | WO | disclosed |